CD19-Specific CAR-T: Dr. Georg Schett and colleagues initially described the successful application of CD19-targeted CAR-T cells in a 20-year-old woman suffering from severe, refractory SLE (178). Here, CD19 is linked to systemic lupus erythematosus.